

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of triglyceride catabolic process (GO:0010896) | 9.60468895 |
| 2 | phospholipid efflux (GO:0033700) | 8.89259078 |
| 3 | high-density lipoprotein particle remodeling (GO:0034375) | 8.80732115 |
| 4 | reverse cholesterol transport (GO:0043691) | 7.66550091 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.07718311 |
| 6 | cholesterol efflux (GO:0033344) | 6.75914965 |
| 7 | regulation of cholesterol esterification (GO:0010872) | 6.75037961 |
| 8 | protein-lipid complex remodeling (GO:0034368) | 6.65542397 |
| 9 | macromolecular complex remodeling (GO:0034367) | 6.65542397 |
| 10 | plasma lipoprotein particle remodeling (GO:0034369) | 6.65542397 |
| 11 | * cellular response to zinc ion (GO:0071294) | 6.65497056 |
| 12 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.52921906 |
| 13 | negative regulation of sterol transport (GO:0032372) | 6.50807920 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 6.50807920 |
| 15 | plasma lipoprotein particle assembly (GO:0034377) | 6.47853597 |
| 16 | drug catabolic process (GO:0042737) | 6.25479898 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 6.23767063 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.23767063 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.16850080 |
| 20 | protein carboxylation (GO:0018214) | 6.16850080 |
| 21 | omega-hydroxylase P450 pathway (GO:0097267) | 6.04541484 |
| 22 | epoxygenase P450 pathway (GO:0019373) | 6.01424540 |
| 23 | exogenous drug catabolic process (GO:0042738) | 5.96035846 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 5.85542702 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.85542702 |
| 26 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.85069182 |
| 27 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.85069182 |
| 28 | protein-lipid complex assembly (GO:0065005) | 5.79619325 |
| 29 | negative regulation of lipase activity (GO:0060192) | 5.36826225 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.19462947 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.18644699 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 5.18065163 |
| 33 | glyoxylate metabolic process (GO:0046487) | 5.15897210 |
| 34 | acylglycerol homeostasis (GO:0055090) | 5.01243264 |
| 35 | triglyceride homeostasis (GO:0070328) | 5.01243264 |
| 36 | plasma lipoprotein particle organization (GO:0071827) | 4.97780231 |
| 37 | cellular response to cadmium ion (GO:0071276) | 4.91732260 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.88812404 |
| 39 | drug metabolic process (GO:0017144) | 4.86610159 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.81455955 |
| 41 | protein-lipid complex subunit organization (GO:0071825) | 4.69656892 |
| 42 | opsonization (GO:0008228) | 4.69223635 |
| 43 | regulation of complement activation (GO:0030449) | 4.63691385 |
| 44 | ethanol oxidation (GO:0006069) | 4.62670975 |
| 45 | regulation of lipoprotein particle clearance (GO:0010984) | 4.37301711 |
| 46 | positive regulation of lipid catabolic process (GO:0050996) | 4.35983711 |
| 47 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.24213971 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 4.24107918 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 4.24107918 |
| 50 | tryptophan catabolic process (GO:0006569) | 4.24107918 |
| 51 | fibrinolysis (GO:0042730) | 4.22397677 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 4.19326515 |
| 53 | regulation of triglyceride metabolic process (GO:0090207) | 4.01096719 |
| 54 | cytolysis (GO:0019835) | 3.98821874 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 3.96421904 |
| 56 | S-adenosylmethionine metabolic process (GO:0046500) | 3.95742396 |
| 57 | regulation of lipoprotein metabolic process (GO:0050746) | 3.95294361 |
| 58 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93278673 |
| 59 | cholesterol transport (GO:0030301) | 3.90746197 |
| 60 | sterol transport (GO:0015918) | 3.90746197 |
| 61 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.90317632 |
| 62 | glucosamine-containing compound catabolic process (GO:1901072) | 3.88609803 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.85217283 |
| 64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.82959113 |
| 65 | lipoprotein metabolic process (GO:0042157) | 3.75012510 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.71316204 |
| 67 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.65152339 |
| 68 | amine catabolic process (GO:0009310) | 3.59242356 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.59242356 |
| 70 | oxidative demethylation (GO:0070989) | 3.57367149 |
| 71 | protein activation cascade (GO:0072376) | 3.55878818 |
| 72 | regulation of sterol transport (GO:0032371) | 3.54158330 |
| 73 | regulation of cholesterol transport (GO:0032374) | 3.54158330 |
| 74 | positive regulation of chemokine secretion (GO:0090197) | 3.53443039 |
| 75 | ethanol metabolic process (GO:0006067) | 3.51064405 |
| 76 | tryptophan metabolic process (GO:0006568) | 3.50264708 |
| 77 | phenylpropanoid metabolic process (GO:0009698) | 3.44324824 |
| 78 | urea metabolic process (GO:0019627) | 3.42464402 |
| 79 | cell wall macromolecule metabolic process (GO:0044036) | 3.42044366 |
| 80 | tyrosine metabolic process (GO:0006570) | 3.41059503 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.39994297 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.36904112 |
| 83 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.36625664 |
| 84 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.31745993 |
| 85 | complement activation (GO:0006956) | 3.31504078 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.28388870 |
| 87 | regulation of lipoprotein lipase activity (GO:0051004) | 3.26540073 |
| 88 | negative regulation of lipid catabolic process (GO:0050995) | 3.25583365 |
| 89 | glycine metabolic process (GO:0006544) | 3.25216042 |
| 90 | negative regulation of hemostasis (GO:1900047) | 3.24543554 |
| 91 | negative regulation of blood coagulation (GO:0030195) | 3.24543554 |
| 92 | neutral lipid catabolic process (GO:0046461) | 3.23406562 |
| 93 | acylglycerol catabolic process (GO:0046464) | 3.23406562 |
| 94 | sterol homeostasis (GO:0055092) | 3.21239741 |
| 95 | regulation of chemokine secretion (GO:0090196) | 3.20640759 |
| 96 | regulation of humoral immune response (GO:0002920) | 3.20522080 |
| 97 | bile acid metabolic process (GO:0008206) | 3.20483676 |
| 98 | L-ascorbic acid metabolic process (GO:0019852) | 3.18039628 |
| 99 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.17934411 |
| 100 | nitrogen cycle metabolic process (GO:0071941) | 3.15479623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.10837661 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.41404975 |
| 3 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.35498169 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64772836 |
| 5 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.41177355 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.01634156 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67990175 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.60530272 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.26550497 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.15906807 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97897806 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.93172582 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89062573 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.28367684 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16881325 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.94006091 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93425156 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81054883 |
| 19 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.78788474 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69150225 |
| 21 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63671296 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.60701509 |
| 23 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.57201643 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53675701 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52477260 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41531843 |
| 27 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.35814787 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35738883 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35599050 |
| 30 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33745249 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33456376 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31994221 |
| 33 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.23436965 |
| 34 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.22557040 |
| 35 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21311548 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19408537 |
| 37 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.18762036 |
| 38 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16756173 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16080665 |
| 40 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15366279 |
| 41 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15366279 |
| 42 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.14725644 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14020278 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13136351 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10229849 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09305644 |
| 47 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09277176 |
| 48 | P300_27268052_Chip-Seq_Bcells_Human | 1.09039478 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08483536 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08104766 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05459815 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05365633 |
| 53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04892461 |
| 54 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04504411 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04375332 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04245164 |
| 57 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.03324990 |
| 58 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02599235 |
| 59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01558577 |
| 60 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.01355708 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01167067 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00549893 |
| 63 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98197288 |
| 64 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97864623 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97571519 |
| 66 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.97330144 |
| 67 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97321267 |
| 68 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96170731 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95658379 |
| 70 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93953803 |
| 71 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93906062 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93523368 |
| 73 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91277256 |
| 74 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.90443523 |
| 75 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89252742 |
| 76 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87782704 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87412943 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.87253532 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87011914 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.86456393 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85801182 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85765411 |
| 83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85486346 |
| 84 | CBP_21632823_ChIP-Seq_H3396_Human | 0.84067734 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83959124 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83753887 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83335904 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82684956 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82175676 |
| 90 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.82111029 |
| 91 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81401659 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80575165 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80256897 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.80088986 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78665105 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78183546 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78107936 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77037854 |
| 99 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.76826068 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76280184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 8.84504003 |
| 2 | MP0005360_urolithiasis | 7.23414877 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.20811025 |
| 4 | MP0003195_calcinosis | 4.57836728 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.25102124 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.53791407 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.42844804 |
| 8 | MP0005365_abnormal_bile_salt | 3.03258117 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.88120327 |
| 10 | MP0005332_abnormal_amino_acid | 2.85846378 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.56618858 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.41898285 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.27977539 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.09627318 |
| 15 | MP0003252_abnormal_bile_duct | 2.07122174 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.01005010 |
| 17 | MP0003878_abnormal_ear_physiology | 1.96671245 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 1.96671245 |
| 19 | MP0001764_abnormal_homeostasis | 1.69614412 |
| 20 | MP0009785_altered_susceptibility_to | 1.64181380 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.59976972 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.57510626 |
| 23 | MP0003186_abnormal_redox_activity | 1.49402387 |
| 24 | MP0000609_abnormal_liver_physiology | 1.45643484 |
| 25 | MP0004270_analgesia | 1.42939295 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 1.33171848 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.29822806 |
| 28 | MP0006082_CNS_inflammation | 1.25971054 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.24007233 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.16622433 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.16061133 |
| 32 | MP0009697_abnormal_copulation | 1.15243439 |
| 33 | MP0005670_abnormal_white_adipose | 1.13048206 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.08920468 |
| 35 | MP0008469_abnormal_protein_level | 1.06188970 |
| 36 | MP0009764_decreased_sensitivity_to | 1.03986031 |
| 37 | MP0005448_abnormal_energy_balance | 1.03348152 |
| 38 | MP0002971_abnormal_brown_adipose | 1.02533530 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02082428 |
| 40 | MP0005671_abnormal_response_to | 1.00649467 |
| 41 | MP0009642_abnormal_blood_homeostasis | 1.00029799 |
| 42 | MP0002078_abnormal_glucose_homeostasis | 0.93159745 |
| 43 | MP0002132_abnormal_respiratory_system | 0.91170590 |
| 44 | MP0002909_abnormal_adrenal_gland | 0.90665569 |
| 45 | MP0008872_abnormal_physiological_respon | 0.88233741 |
| 46 | MP0009763_increased_sensitivity_to | 0.88044852 |
| 47 | MP0005535_abnormal_body_temperature | 0.87202809 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.84696285 |
| 49 | MP0003011_delayed_dark_adaptation | 0.84194785 |
| 50 | MP0001835_abnormal_antigen_presentation | 0.82817988 |
| 51 | MP0002254_reproductive_system_inflammat | 0.81824458 |
| 52 | MP0010155_abnormal_intestine_physiology | 0.81183607 |
| 53 | MP0003690_abnormal_glial_cell | 0.81016180 |
| 54 | MP0005464_abnormal_platelet_physiology | 0.80745007 |
| 55 | MP0005395_other_phenotype | 0.78809290 |
| 56 | MP0005334_abnormal_fat_pad | 0.78574715 |
| 57 | MP0002822_catalepsy | 0.77260308 |
| 58 | MP0001845_abnormal_inflammatory_respons | 0.77006969 |
| 59 | MP0005379_endocrine/exocrine_gland_phen | 0.76660261 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 0.76465835 |
| 61 | MP0000604_amyloidosis | 0.75746925 |
| 62 | MP0003045_fibrosis | 0.74872285 |
| 63 | MP0005164_abnormal_response_to | 0.73164923 |
| 64 | MP0001756_abnormal_urination | 0.71990599 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.71957624 |
| 66 | MP0005025_abnormal_response_to | 0.71584201 |
| 67 | MP0003436_decreased_susceptibility_to | 0.71277532 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.70889879 |
| 69 | MP0003879_abnormal_hair_cell | 0.70744124 |
| 70 | MP0000685_abnormal_immune_system | 0.70565755 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.70279405 |
| 72 | MP0005408_hypopigmentation | 0.69824097 |
| 73 | MP0005000_abnormal_immune_tolerance | 0.69345301 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.69207178 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 0.69131628 |
| 76 | MP0000249_abnormal_blood_vessel | 0.68272235 |
| 77 | MP0002168_other_aberrant_phenotype | 0.67178884 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.66780446 |
| 79 | MP0003868_abnormal_feces_composition | 0.65858616 |
| 80 | MP0000598_abnormal_liver_morphology | 0.65364678 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.63075415 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.62943442 |
| 83 | MP0004142_abnormal_muscle_tone | 0.62842042 |
| 84 | MP0001790_abnormal_immune_system | 0.62538759 |
| 85 | MP0005387_immune_system_phenotype | 0.62538759 |
| 86 | MP0003718_maternal_effect | 0.60723568 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.60384628 |
| 88 | MP0003953_abnormal_hormone_level | 0.59157891 |
| 89 | MP0001800_abnormal_humoral_immune | 0.58800092 |
| 90 | MP0004883_abnormal_blood_vessel | 0.57082531 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.56374157 |
| 92 | MP0005166_decreased_susceptibility_to | 0.55354892 |
| 93 | MP0003646_muscle_fatigue | 0.52076982 |
| 94 | MP0002163_abnormal_gland_morphology | 0.51270286 |
| 95 | MP0005266_abnormal_metabolism | 0.51093101 |
| 96 | MP0002090_abnormal_vision | 0.51044524 |
| 97 | MP0002419_abnormal_innate_immunity | 0.50859062 |
| 98 | MP0003075_altered_response_to | 0.50445846 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.50058901 |
| 100 | MP0002970_abnormal_white_adipose | 0.50013140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperlipoproteinemia (HP:0010980) | 8.19817052 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.56293834 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 7.44055449 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.35486155 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.60161212 |
| 6 | Complement deficiency (HP:0004431) | 6.12887332 |
| 7 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.90608951 |
| 8 | Hypolipoproteinemia (HP:0010981) | 5.80591756 |
| 9 | Joint hemorrhage (HP:0005261) | 5.67839496 |
| 10 | Abnormality of complement system (HP:0005339) | 5.01598005 |
| 11 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.68742960 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.59329648 |
| 13 | Hyperglycinemia (HP:0002154) | 4.12453505 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88070609 |
| 15 | Malnutrition (HP:0004395) | 3.82309859 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81024277 |
| 17 | Pigmentary retinal degeneration (HP:0001146) | 3.68283225 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44664695 |
| 19 | Xanthomatosis (HP:0000991) | 3.32732193 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.32094107 |
| 21 | Delayed CNS myelination (HP:0002188) | 3.28978333 |
| 22 | Gingival bleeding (HP:0000225) | 3.26387735 |
| 23 | Hyperammonemia (HP:0001987) | 3.17426131 |
| 24 | Spontaneous abortion (HP:0005268) | 3.14088574 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.08430711 |
| 26 | Nausea (HP:0002018) | 2.94802524 |
| 27 | Increased serum ferritin (HP:0003281) | 2.94202971 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.88745504 |
| 29 | Generalized aminoaciduria (HP:0002909) | 2.87633124 |
| 30 | Tetany (HP:0001281) | 2.86956894 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78724976 |
| 32 | Hypomagnesemia (HP:0002917) | 2.77957707 |
| 33 | Metabolic acidosis (HP:0001942) | 2.76907346 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.74179831 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.74179831 |
| 36 | Abnormality of magnesium homeostasis (HP:0004921) | 2.73567792 |
| 37 | Arthropathy (HP:0003040) | 2.72997281 |
| 38 | Vascular calcification (HP:0004934) | 2.66633225 |
| 39 | Abnormality of iron homeostasis (HP:0011031) | 2.60129914 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58564810 |
| 41 | Prolonged neonatal jaundice (HP:0006579) | 2.56749130 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.56003993 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55924970 |
| 44 | Glomerulonephritis (HP:0000099) | 2.51025229 |
| 45 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.44538368 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.38194551 |
| 47 | Menorrhagia (HP:0000132) | 2.34022351 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.33918379 |
| 49 | Fat malabsorption (HP:0002630) | 2.31621498 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29090316 |
| 51 | Mitral stenosis (HP:0001718) | 2.26717738 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21027445 |
| 53 | Neonatal hypoglycemia (HP:0001998) | 2.17787167 |
| 54 | Acute encephalopathy (HP:0006846) | 2.16773450 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.14215468 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12402430 |
| 57 | Ketosis (HP:0001946) | 2.10768479 |
| 58 | Steatorrhea (HP:0002570) | 2.07952894 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.07674677 |
| 60 | Joint swelling (HP:0001386) | 2.06563420 |
| 61 | Pancreatitis (HP:0001733) | 2.04529088 |
| 62 | Cerebral edema (HP:0002181) | 2.01884135 |
| 63 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01711118 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 10.1222577 |
| 65 | Hyperglycinuria (HP:0003108) | 1.97689304 |
| 66 | Hyperbilirubinemia (HP:0002904) | 1.96417733 |
| 67 | Retinal atrophy (HP:0001105) | 1.96264224 |
| 68 | Attenuation of retinal blood vessels (HP:0007843) | 1.94110852 |
| 69 | Amyloidosis (HP:0011034) | 1.92520962 |
| 70 | Nephritis (HP:0000123) | 1.92156109 |
| 71 | Hepatic necrosis (HP:0002605) | 1.84551154 |
| 72 | Hepatocellular necrosis (HP:0001404) | 1.82823813 |
| 73 | Lethargy (HP:0001254) | 1.81066373 |
| 74 | Glycosuria (HP:0003076) | 1.80578322 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 1.80578322 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 1.79460853 |
| 77 | Mitochondrial inheritance (HP:0001427) | 1.78827990 |
| 78 | Opisthotonus (HP:0002179) | 1.78722547 |
| 79 | Congenital sensorineural hearing impairment (HP:0008527) | 1.78135681 |
| 80 | Irritability (HP:0000737) | 1.77863586 |
| 81 | Thrombophlebitis (HP:0004418) | 1.77777179 |
| 82 | Fair hair (HP:0002286) | 1.76443580 |
| 83 | Severe visual impairment (HP:0001141) | 1.73826559 |
| 84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71367436 |
| 85 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71367436 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70969950 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70633129 |
| 88 | Proximal tubulopathy (HP:0000114) | 1.68206142 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 1.66599686 |
| 90 | Choroideremia (HP:0001139) | 1.61937993 |
| 91 | Optic disc pallor (HP:0000543) | 1.61087518 |
| 92 | Vomiting (HP:0002013) | 1.58881728 |
| 93 | Purpura (HP:0000979) | 1.58240852 |
| 94 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.57514144 |
| 95 | Alkalosis (HP:0001948) | 1.55212048 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 1.55026004 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 1.52728132 |
| 98 | Nephrolithiasis (HP:0000787) | 1.51917689 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.51693463 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 1.51693463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 7.48700883 |
| 2 | MUSK | 6.67292655 |
| 3 | TESK2 | 5.46251175 |
| 4 | MAP3K12 | 5.10600683 |
| 5 | BCKDK | 3.38336242 |
| 6 | KDR | 3.15187167 |
| 7 | MAP4K1 | 2.80046377 |
| 8 | MAP3K11 | 2.25018236 |
| 9 | LIMK1 | 2.05780289 |
| 10 | TAOK3 | 1.82122617 |
| 11 | ERN1 | 1.80884465 |
| 12 | ACVR1B | 1.73257154 |
| 13 | ARAF | 1.61681436 |
| 14 | MYLK | 1.43823844 |
| 15 | CSF1R | 1.41251783 |
| 16 | MST4 | 1.32320743 |
| 17 | BLK | 1.30069944 |
| 18 | ABL2 | 1.21049066 |
| 19 | TYK2 | 1.19780545 |
| 20 | NLK | 1.14148236 |
| 21 | EPHA3 | 1.11546856 |
| 22 | WNK3 | 1.10039916 |
| 23 | MAPKAPK3 | 1.03757533 |
| 24 | LMTK2 | 1.00526362 |
| 25 | FGFR4 | 1.00262087 |
| 26 | TESK1 | 0.99362350 |
| 27 | ADRBK2 | 0.97631297 |
| 28 | GRK1 | 0.97105800 |
| 29 | EPHB1 | 0.94638186 |
| 30 | ZAP70 | 0.93095007 |
| 31 | ADRBK1 | 0.87523439 |
| 32 | TAOK2 | 0.87191637 |
| 33 | GRK7 | 0.82016049 |
| 34 | MAP3K9 | 0.78139426 |
| 35 | MAPK11 | 0.76058607 |
| 36 | IRAK2 | 0.73373816 |
| 37 | IRAK1 | 0.71081119 |
| 38 | DAPK1 | 0.70770152 |
| 39 | FRK | 0.69103809 |
| 40 | FGFR2 | 0.68166713 |
| 41 | NME1 | 0.66553306 |
| 42 | MAP3K1 | 0.65865608 |
| 43 | MARK3 | 0.62677062 |
| 44 | PRKCG | 0.62427480 |
| 45 | MAP3K13 | 0.61263831 |
| 46 | ILK | 0.61213682 |
| 47 | ITK | 0.61083837 |
| 48 | PRKCI | 0.59780263 |
| 49 | CAMKK2 | 0.58688357 |
| 50 | JAK1 | 0.57572181 |
| 51 | MAP3K5 | 0.55916180 |
| 52 | MAP2K6 | 0.55238699 |
| 53 | STK16 | 0.52825752 |
| 54 | TXK | 0.52716361 |
| 55 | PIM2 | 0.52656157 |
| 56 | IRAK3 | 0.51729560 |
| 57 | PRKCE | 0.49571738 |
| 58 | PRKG2 | 0.48415745 |
| 59 | PAK4 | 0.48388583 |
| 60 | SYK | 0.48327168 |
| 61 | VRK2 | 0.47929144 |
| 62 | PDK1 | 0.47676539 |
| 63 | PTK6 | 0.47061138 |
| 64 | IKBKB | 0.45329501 |
| 65 | JAK3 | 0.44559910 |
| 66 | TNIK | 0.42657328 |
| 67 | AKT2 | 0.42244826 |
| 68 | PRKCQ | 0.42212750 |
| 69 | DYRK2 | 0.41081449 |
| 70 | BUB1 | 0.38709806 |
| 71 | CAMK2D | 0.37373856 |
| 72 | RPS6KA5 | 0.34970071 |
| 73 | MAP2K4 | 0.32757894 |
| 74 | FER | 0.31570842 |
| 75 | CAMK2G | 0.30848302 |
| 76 | PRKD1 | 0.30433297 |
| 77 | PRKACG | 0.29957836 |
| 78 | LCK | 0.28858019 |
| 79 | SCYL2 | 0.26343913 |
| 80 | CSNK1A1 | 0.25943971 |
| 81 | INSRR | 0.25576236 |
| 82 | WNK4 | 0.25549419 |
| 83 | TBK1 | 0.25292667 |
| 84 | PASK | 0.25199813 |
| 85 | TLK1 | 0.25036530 |
| 86 | LYN | 0.24991908 |
| 87 | NTRK3 | 0.24730341 |
| 88 | PRKCA | 0.24001107 |
| 89 | IGF1R | 0.23981934 |
| 90 | MAPK15 | 0.23954431 |
| 91 | GRK5 | 0.21882872 |
| 92 | ZAK | 0.21684934 |
| 93 | CSK | 0.20903160 |
| 94 | PDPK1 | 0.20772877 |
| 95 | IKBKE | 0.19359237 |
| 96 | DYRK3 | 0.18495495 |
| 97 | CAMK2B | 0.17465512 |
| 98 | PRKACA | 0.16963206 |
| 99 | LRRK2 | 0.16709061 |
| 100 | PRKAA2 | 0.16577128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.77587816 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.75945767 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.47638200 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10116166 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.90274695 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90080075 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85923676 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78520453 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.73094108 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.70356287 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.59244034 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39660401 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27695496 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.16093093 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.10228725 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.07575328 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05176290 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02639519 |
| 19 | * Mineral absorption_Homo sapiens_hsa04978 | 1.94031556 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90794309 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87242971 |
| 22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.79776677 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79094999 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66529186 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65613318 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53203666 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52656624 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49845272 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.49686650 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38934634 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36899888 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29875170 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.28273372 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24770456 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22299097 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19190300 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14764927 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09585582 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06302515 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05478912 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.05400774 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.05350867 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03040736 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00354976 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 0.93469347 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91407719 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90767341 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87612999 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86462334 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83404987 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82464402 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81157528 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80368670 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79151638 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78004382 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76847951 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76480358 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76376713 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72250888 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71084685 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70727272 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70544405 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69604808 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69584007 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.64867533 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64847764 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63645604 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61024876 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60354696 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60126957 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.58509369 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56546549 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.54702208 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53961648 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53377969 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51873238 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50086081 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39458763 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37405551 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36477922 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34831561 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32700079 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27296181 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.24691885 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22398190 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21304036 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21162302 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20484026 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19979795 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.14418702 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13298590 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13234953 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11501780 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.10833907 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.09826373 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09672074 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08328360 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06913283 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04819745 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03919104 |

